A phase I trial of recombinant human interleukin-1β alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer
- Author
- CROWN, J; JAKUBOWSKI, A; APPLEWHITE, J; SHININ SINHA; MOORE, M; KELSEN, D; BUHLES, W; GABRILOVE, J; KEMENY, N; GORDON, M; GASPARETTO, C; WONG, G; SHERIDAN, C; TONER, G; MEISENBERG, B; BOTET, J
Memorial Sloan-Kettering cancer cent., New York NY, United States - Source
Blood. 1991, Vol 78, Num 6, pp 1420-1427 ; ref : 38 ref
- ISSN
- 0006-4971
- Scientific domain
- Medical oncology; Hematology
- Publisher
- The Americain Society of Hematology, Washington, DC
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Appareil digestif pathologie Chimiothérapie Essai clinique phase I Fluorouracil Homme Hématopoïèse Interleukine 1 Neutropénie Protéine recombinante Traitement associé Traitement Tumeur maligne
- Keyword (en)
- Antineoplastic agent Digestive diseases Chemotherapy Phase I trial Human Hematopoiesis Interleukin 1 Neutropenia Recombinant protein Combined treatment Treatment Malignant tumor
- Keyword (es)
- Anticanceroso Aparato digestivo patología Quimioterapia Ensayo clínico fase I Hombre Hematopoyesis Interleuquina 1 Neutropenia Proteína recombinante Tratamiento asociado Tratamiento Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 5454709
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1182/blood.V78.6.1420.1420 
https://dx.doi.org/10.1182/blood.V78.6.1420.1420
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1182\/blood.V78.6.1420.1420\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:164:\"A phase I trial of recombinant human interleukin-1\u03b2 alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1991\";s:9:\"\u0000*\u0000volume\";s:2:\"78\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1420\";s:8:\"\u0000*\u0000epage\";s:4:\"1427\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CROWN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:13:\"JAKUBOWSKI, A\";i:1;s:13:\"APPLEWHITE, J\";i:2;s:12:\"SHININ SINHA\";i:3;s:8:\"MOORE, M\";i:4;s:9:\"KELSEN, D\";i:5;s:9:\"BUHLES, W\";i:6;s:12:\"GABRILOVE, J\";i:7;s:9:\"KEMENY, N\";i:8;s:9:\"GORDON, M\";i:9;s:13:\"GASPARETTO, C\";i:10;s:7:\"WONG, G\";i:11;s:11:\"SHERIDAN, C\";i:12;s:8:\"TONER, G\";i:13;s:13:\"MEISENBERG, B\";i:14;s:8:\"BOTET, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:164:\"A phase I trial of recombinant human interleukin-1\u03b2 alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1182\/blood.V78.6.1420.1420\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:164:\"A phase I trial of recombinant human interleukin-1\u03b2 alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1991\";s:9:\"\u0000*\u0000volume\";s:2:\"78\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1420\";s:8:\"\u0000*\u0000epage\";s:4:\"1427\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CROWN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:13:\"JAKUBOWSKI, A\";i:1;s:13:\"APPLEWHITE, J\";i:2;s:12:\"SHININ SINHA\";i:3;s:8:\"MOORE, M\";i:4;s:9:\"KELSEN, D\";i:5;s:9:\"BUHLES, W\";i:6;s:12:\"GABRILOVE, J\";i:7;s:9:\"KEMENY, N\";i:8;s:9:\"GORDON, M\";i:9;s:13:\"GASPARETTO, C\";i:10;s:7:\"WONG, G\";i:11;s:11:\"SHERIDAN, C\";i:12;s:8:\"TONER, G\";i:13;s:13:\"MEISENBERG, B\";i:14;s:8:\"BOTET, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:164:\"A phase I trial of recombinant human interleukin-1\u03b2 alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1182\/blood.V78.6.1420.1420\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1182\/blood.V78.6.1420.1420\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:164:\"A phase I trial of recombinant human interleukin-1\u03b2 alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1991\";s:9:\"\u0000*\u0000volume\";s:2:\"78\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1420\";s:8:\"\u0000*\u0000epage\";s:4:\"1427\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CROWN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:13:\"JAKUBOWSKI, A\";i:1;s:13:\"APPLEWHITE, J\";i:2;s:12:\"SHININ SINHA\";i:3;s:8:\"MOORE, M\";i:4;s:9:\"KELSEN, D\";i:5;s:9:\"BUHLES, W\";i:6;s:12:\"GABRILOVE, J\";i:7;s:9:\"KEMENY, N\";i:8;s:9:\"GORDON, M\";i:9;s:13:\"GASPARETTO, C\";i:10;s:7:\"WONG, G\";i:11;s:11:\"SHERIDAN, C\";i:12;s:8:\"TONER, G\";i:13;s:13:\"MEISENBERG, B\";i:14;s:8:\"BOTET, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:164:\"A phase I trial of recombinant human interleukin-1\u03b2 alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1182\/blood.V78.6.1420.1420\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:164:\"A phase I trial of recombinant human interleukin-1\u03b2 alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1991\";s:9:\"\u0000*\u0000volume\";s:2:\"78\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1420\";s:8:\"\u0000*\u0000epage\";s:4:\"1427\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CROWN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:13:\"JAKUBOWSKI, A\";i:1;s:13:\"APPLEWHITE, J\";i:2;s:12:\"SHININ SINHA\";i:3;s:8:\"MOORE, M\";i:4;s:9:\"KELSEN, D\";i:5;s:9:\"BUHLES, W\";i:6;s:12:\"GABRILOVE, J\";i:7;s:9:\"KEMENY, N\";i:8;s:9:\"GORDON, M\";i:9;s:13:\"GASPARETTO, C\";i:10;s:7:\"WONG, G\";i:11;s:11:\"SHERIDAN, C\";i:12;s:8:\"TONER, G\";i:13;s:13:\"MEISENBERG, B\";i:14;s:8:\"BOTET, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:164:\"A phase I trial of recombinant human interleukin-1\u03b2 alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1182\/blood.V78.6.1420.1420\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:164:\"A phase I trial of recombinant human interleukin-1\u03b2 alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Blood\";s:9:\"\u0000*\u0000stitle\";s:5:\"Blood\";s:7:\"\u0000*\u0000date\";s:4:\"1991\";s:9:\"\u0000*\u0000volume\";s:2:\"78\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1420\";s:8:\"\u0000*\u0000epage\";s:4:\"1427\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0006-4971\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CROWN\";s:10:\"\u0000*\u0000aufirst\";s:1:\"J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:15:{i:0;s:13:\"JAKUBOWSKI, A\";i:1;s:13:\"APPLEWHITE, J\";i:2;s:12:\"SHININ SINHA\";i:3;s:8:\"MOORE, M\";i:4;s:9:\"KELSEN, D\";i:5;s:9:\"BUHLES, W\";i:6;s:12:\"GABRILOVE, J\";i:7;s:9:\"KEMENY, N\";i:8;s:9:\"GORDON, M\";i:9;s:13:\"GASPARETTO, C\";i:10;s:7:\"WONG, G\";i:11;s:11:\"SHERIDAN, C\";i:12;s:8:\"TONER, G\";i:13;s:13:\"MEISENBERG, B\";i:14;s:8:\"BOTET, J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:164:\"A phase I trial of recombinant human interleukin-1\u03b2 alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer\";s:8:\"\u0000*\u0000place\";s:14:\"Washington, DC\";s:6:\"\u0000*\u0000pub\";s:35:\"The Americain Society of Hematology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
